Patent ID: 9486449
Filing Date: 2016-11-08
CPC Classification: A61K

Claim Text:
1. A method for the treatment of cancer in a subject, said method comprising orally administering to said subject an amount of a compound selected from the group consisting of N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide (PJ-34), 6-(5H)-phenanthridinone (Phen) and any pharmaceutically acceptable salt of any of said compounds, wherein the compound is administered in an amount of 30 mg/kg body weight/day to 120 mg/kg body weight/day and has a lethal effect on the cells of said cancer, and wherein said cancer is selected from the group consisting of breast cancer, lung cancer, pancreatic cancer, ovarian cancer, colon cancer, glioblastoma and leukemia.